Your browser doesn't support javascript.
loading
Endotrophin neutralization through targeted antibody treatment protects from renal fibrosis in a podocyte ablation model.
An, Yu A; Xiong, Wei; Chen, Shiuhwei; Bu, Dawei; Rutkowski, Joseph M; Berger, Joel P; Kusminski, Christine M; Zhang, Ningyan; An, Zhiqiang; Scherer, Philipp E.
Afiliación
  • An YA; Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Xiong W; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Chen S; Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Bu D; Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Rutkowski JM; Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Division of Lymphatic Biology, Department of Medical Physiology, Texas A&M University School of Medicine, Bryan, TX, USA.
  • Berger JP; JP Berger Consulting, 580 Washington Street, #15C, Boston, MA, USA.
  • Kusminski CM; Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Zhang N; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • An Z; Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Scherer PE; Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Philipp.Scherer@UTSouthwestern.edu.
Mol Metab ; 69: 101680, 2023 03.
Article en En | MEDLINE | ID: mdl-36696925

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Podocitos / Insuficiencia Renal Crónica Límite: Animals Idioma: En Revista: Mol Metab Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Podocitos / Insuficiencia Renal Crónica Límite: Animals Idioma: En Revista: Mol Metab Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos